Paolo Paganetti
Lugano, TI 6900, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Nucleoside-Analog Reverse-Transcriptase Inhibitors (NRTIs) Against Multiple Sclerosis: Comprehensive Review on a Possible Novel Therapeutic Approach.
Journal: Neurology international
Published: April 30, 2026
High Tau expression correlates with reduced invasion and prolonged survival in Ewing sarcoma.
Journal: Cell death discovery
Published: March 24, 2025
Prognostic and Biological Roles of Parkinson's Disease-Associated Genes in Cancer.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: March 24, 2025
A novel allosteric GCase modulator prevents Tau accumulation in GBA1WT and GBA1L444P/L444P cellular models.
Journal: Scientific reports
Published: October 26, 2024
Tau protein modulates an epigenetic mechanism of cellular senescence in human SH-SY5Y neuroblastoma cells.
Journal: Frontiers in cell and developmental biology
Published: June 01, 2023
Tau accumulation in degradative organelles is associated to lysosomal stress.
Journal: Scientific reports
Published: May 23, 2023
Tau protein binds to the P53 E3 ubiquitin ligase MDM2.
Journal: Scientific reports
Published: January 09, 2023
Whole-brain microscopy reveals distinct temporal and spatial efficacy of anti-Aβ therapies.
Journal: EMBO molecular medicine
Published: August 24, 2022
Loss of TDP-43 oligomerization or RNA binding elicits distinct aggregation patterns.
Journal: The EMBO journal
Published: May 20, 2022
Last Updated: 09/26/2026